| Advantages of an electrochemical method compared to the spectrophotometric kinetic study of peroxidase inhibition by boroxine derivative J Ostojić, S Herenda, Z Bešić, M Miloš, B Galić Molecules 22 (7), 1120, 2017 | 57 | 2017 |
| Dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], is a potent inhibitor of human carbonic anhydrases D Vullo, M Milos, B Galic, A Scozzafava, CT Supuran Journal of enzyme inhibition and medicinal chemistry 30 (2), 341-344, 2015 | 35 | 2015 |
| A study of the inhibition of catalase by dipotassium trioxohydroxytetrafluorotriborate K2 [B3O3F4OH] S Islamovic, B Galic, M Milos Journal of enzyme inhibition and medicinal chemistry 29 (5), 744-748, 2014 | 31 | 2014 |
| In vitro and in vivo antitumor activity of the halogenated boroxine dipotassium-trioxohydroxytetrafluorotriborate (K2 [B3O3F4OH]) S Ivankovic, R Stojkovic, Z Galic, B Galic, J Ostojic, M Marasovic, M Milos Journal of enzyme inhibition and medicinal chemistry 30 (3), 354-359, 2015 | 29 | 2015 |
| Effects of dipotassium trioxohydroxytetrafluorotriborate (K2[B3O3F4OH]) on genetic material and inhibition of cell division in human cell cultures S Haveric, A Haveric, K Bajrovic, B Galic, M Maksimovic Drug and Chemical Toxicology 34 (3), 250-254, 2011 | 25 | 2011 |
| In vitro and in vivo antitumour effects of phenylboronic acid against mouse mammary adenocarcinoma 4T1 and squamous carcinoma SCCVII cells M Marasovic, S Ivankovic, R Stojkovic, D Djermic, B Galic, M Milos Journal of enzyme inhibition and medicinal chemistry 32 (1), 1299-1304, 2017 | 19 | 2017 |
| Inhibitory effects of delphinidin and luteolin on genotoxicity induced by K2B3O3F4OH) in human lymphocytes in vitro M Hadžić, S Haverić, A Haverić, B Galić Biologia 70, 553-558, 2015 | 18 | 2015 |
| Inhibition of Horseradish Peroxidase Activity by Boroxine Derivative, Dipotassium-trioxohydroxytetrafluorotriborate K2[B3O3F4OH] J Ostojic, S Herenda, S Galijasevic, B Galic, M Milos Journal of Chemistry 2017, 2017 | 16 | 2017 |
| Boroxine composition for removal of skin changes B Galic Patent US 8, 278-289, 2012 | 14 | 2012 |
| Electrochemical investigation of the influence of K2 [B3O3F4OH] on the activity of immobilized superoxide dismutase S Herenda, J Ostojić, E Hasković, D Hasković, M Miloš, B Galić International Journal of Electrochemical Science 13 (4), 3279-3287, 2018 | 13 | 2018 |
| Effects of dipotassium-trioxohydroxytetrafluorotriborate, K2[B3O3F4OH], on cell viability and gene expression of common human cancer drug targets in a … L Pojskic, S Haveric, N Lojo-Kadric, M Hadzic, A Haveric, Z Galic, B Galic, ... Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6), 999-1004, 2016 | 13 | 2016 |
| Impact of calcium ion on cytotoxic effect of the boroxine derivative, K2[B3O3F4OH] S Ivankovic, R Stojkovic, M Maksimovic, B Galic, M Milos Journal of enzyme inhibition and medicinal chemistry 31 (sup3), 70-74, 2016 | 12 | 2016 |
| Bioflavonoids protect cells against halogenated boroxine-induced genotoxic damage by upregulation of hTERT expression M Hadzic, S Haveric, A Haveric, N Lojo-Kadric, B Galic, J Ramic, L Pojskic Zeitschrift für Naturforschung C 74 (5-6), 125-129, 2019 | 9 | 2019 |
| Genotoxicity evaluation of dipotassium-trioxohydroxytetrafluorotriborate, K2 (B3O3F4OH), in human lymphocyte cultures and mice reticulocytes S Haveric, M Hadzic, A Haveric, M Mijanovic, R Hadziselimovic, B Galic Brazilian Archives of Biology and Technology 59, 2016 | 7 | 2016 |
| Biochemical and histomorphological findings in Swiss Wistar rats treated with potential boron-containing therapeutic-K2 [B3O3F4OH] A Haverić, A Durmić-Pašić, A Alić, I Mujezinović, A Smajlović, J Ostojić, ... Journal of Trace Elements in Medicine and Biology 62, 126642, 2020 | 6 | 2020 |
| Halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate K2[B3O3F4OH] inhibits emerging multidrug-resistant and β-lactamase-producing … A Maravić, T Rončević, L Krce, N Ilić, B Galić, V Čulić Čikeš, I Carev Drug development and industrial pharmacy 45 (11), 1770-1776, 2019 | 6 | 2019 |
| Novel boron‐containing compound, halogenated boroxine, induces selective cytotoxicity through apoptosis triggering in UT‐7 leukemia M Hadzic, L Pojskic, N Lojo‐Kadric, A Haveric, J Ramic, B Galic, ... Journal of Biochemical and Molecular Toxicology 36 (5), e23005, 2022 | 5 | 2022 |
| Boroxine composition for removal of skin changes B Galic US Patent 8,278,289, 2012 | 4 | 2012 |
| Quantum Chemical and Biochemical Study on Antioxidant Properties of Halogenated Boroxine K2[B3O3F4OH] M Marasović, T Marasović, B Galić, M Miloš Croatica chemica acta 90 (2), 155-161, 2017 | 3 | 2017 |
| Study of kinetic parameters and possible inhibitory effect on the tyrosinase of the halogenated boroxine dipotassium trioxohydroxytetrafluorotriborate K2 [B303F4OH] M Marasović, Z Čorić, M Miloš, B Galić CBU International Conference Proceedings 4, 700-705, 2016 | 2 | 2016 |
